Talking Turkey: North American Pharma-Bio Sector Brings $34 Billion Future Investment Plans to the Table
Attachment: Pharma-Biotech kickoffs, 2017
SUGAR LAND--November 23, 2016--Reported by Annette Kreuger, Industrial Info Resources (Sugar Land, Texas)--Millions of people in the U.S. this week will celebrate Thanksgiving, but there is no such holiday to express gratitude for the generous bounty of pharmaceutical-biotech capital investment across the country. Perhaps there should be, as this bountiful $34 billion cash crop continues to benefit the local population long after the initial harvest, in terms of employment and a boost in-direct income.
Within this article: Details on some of the highest-valued projects in the Pharmaceutical-Biotech Industry, including those from Novo Nordisk AS (NYSE:NVO), Grifols USA, Oak Ridge National Laboratory and Evonik Corporation.
